Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

4 Stocks To Watch: EBIO, EXEL, NKTR, PBYI

By Harry BoxerStock MarketsAug 23, 2016 12:56AM ET
www.investing.com/analysis/ebio,-exel,-nktr,-pbyi-200149422
4 Stocks To Watch: EBIO, EXEL, NKTR, PBYI
By Harry Boxer   |  Aug 23, 2016 12:56AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

It was a really weird, volatile, up and down day all day on Monday. A kind of consolidation, wedge-type day with no resolution, and a mixed close. A lot of stocks we follow had an interesting day. Some of them may be breaking back out. We might just have to wait and see. In the meantime, let’s take a look at some of them and see what’s going on and what to expect next.

Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) has a phenomenal chart. They recently signed an exclusive licensing deal with Roche, and keep on climbing. It’s a strong rising chart, great OBV, terrific Money Stream / Balance of Power, and great technicals. In the recent action, after spiking and pulling back for three days, it looks like it popped on Monday, up 31 cents to 5.09, or 6.5%, on 1.6 million shares. That’s a little bit of an increase in volume. I want to see this stock take out the 6.00 range, run up to 8-8 1/4, and then a lot higher down the road, but for now, let’s watch that.

Exelixis, Inc. (NASDAQ:EXEL) has had a fantastic move, having gone from 3 1/2 to 11, and change, formed a wedge, broke back out, and on Monday, it was up 44 cents to 11.44, or 4%, on 7.4 million shares. That’s the best volume on an up day in a couple weeks. It looks like that if it could get through the spike high at 11.66, we may be looking at 12 3/4-13 short-term.

Nektar Therapeutics (NASDAQ:NKTR) advanced 57 cents to 17.83, or 3.3%, on 785,097 shares traded on Monday. That was the best volume in two weeks. I’m convinced that when this one does go, it’s going to spike up to 20, and then maybe get to 22 1/2-23, the near-term targets. Look for it to break out of the 18 range, and watch it from there.

Puma Biotechnology, Inc. (NYSE:PBYI) had a nice day on Monday, up 4.56 to 54.65, or 9%, on 1.2 million shares. It appears this stock is at key resistance at the 55 1/2-56 range. Monday’s high was 55.43, so it’s right there. A punch through here is likely to get it up toward 68, which is the next target.

Stocks on the long side included Advaxis, Inc. (NASDAQ:ADXS), Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Arrowhead Research Corp. (NASDAQ:ARWR), A10 Networks, Inc. (NYSE:ATEN), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Cardiovascular Systems Inc. (NASDAQ:CSII), Eleven Biotherapeutics, Inc. (EBIO), Exelixis, Inc. (EXEL), Novatel Wireless Inc. (NASDAQ:MIFI), Momo Inc. (NASDAQ:MOMO), Nektar Therapeutics (NKTR), Puma Biotechnology, Inc. (PBYI), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Resolute Energy Corporation (NYSE:REN), Rovi Corporation (NASDAQ:ROVI), Twilio, Inc. (NYSE:TWLO), and Valeant Pharmaceuticals (NYSE:VRX).

4 Stocks To Watch: EBIO, EXEL, NKTR, PBYI
 

Related Articles

Tim Knight
Another Gap Play For CP By Tim Knight - Oct 21, 2021 2

Canadian Pacific (NYSE:CP) has come almost all the way back to a major price gap. Here’s the bigger picture. It’s doomtastic.

4 Stocks To Watch: EBIO, EXEL, NKTR, PBYI

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email